Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With FUS-ERG+ AML
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01358
Full Text
Open PDFAbstract
Available in full text
Date
December 3, 2019
Authors
Publisher
Frontiers Media SA